{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:06:47Z","timestamp":1772698007634,"version":"3.50.1"},"reference-count":6,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1111\/bcp.15900","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:36:06Z","timestamp":1694421366000},"page":"3463-3464","source":"Crossref","is-referenced-by-count":3,"title":["Urgent call to action: Making gene therapy for Duchenne muscular dystrophy (DMD) affordable and accessible"],"prefix":"10.1111","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-4129","authenticated-orcid":false,"given":"Omar","family":"Alomari","sequence":"first","affiliation":[{"name":"Hamidiye International School of Medicine University of Health Sciences  Istanbul Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"e_1_2_1_6_2_1","unstructured":"U.S. Food and Drug Administration. Accessed August 3 2023.https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-certain-patients-duchenne-muscular-dystrophy"},{"key":"e_1_2_1_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26755"},{"key":"e_1_2_1_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572\u2010021\u201000248\u20103"},{"key":"e_1_2_1_6_5_1","unstructured":"FDA approves first gene therapy for Duchenne muscular dystrophy despite internal objections. Accessed August 4 2023.https:\/\/www.nature.com\/nrd\/articles?type=news-in-brief"},{"key":"e_1_2_1_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010017\u20100631\u20103"},{"key":"e_1_2_1_6_7_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i02a06"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T06:43:05Z","timestamp":1697697785000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1111\/bcp.15900"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15900","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]}}}